BioLineRx (BLRX) Revenue (2023 - 2025)
Historic Revenue for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to $427000.0.
- BioLineRx's Revenue fell 9136.15% to $427000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 million, marking a year-over-year decrease of 3007.74%. This contributed to the annual value of $28.9 million for FY2024, which is 50291.67% up from last year.
- Per BioLineRx's latest filing, its Revenue stood at $427000.0 for Q3 2025, which was down 9136.15% from $304000.0 recorded in Q2 2025.
- BioLineRx's Revenue's 5-year high stood at $11.7 million during Q4 2024, with a 5-year trough of -$630000.0 in Q1 2023.
- Moreover, its 3-year median value for Revenue was $929500.0 (2023), whereas its average is $3.1 million.
- Per our database at Business Quant, BioLineRx's Revenue skyrocketed by 118809.52% in 2024 and then tumbled by 9628.01% in 2025.
- Over the past 3 years, BioLineRx's Revenue (Quarter) stood at $1.0 million in 2023, then skyrocketed by 1049.61% to $11.7 million in 2024, then crashed by 96.37% to $427000.0 in 2025.
- Its Revenue stands at $427000.0 for Q3 2025, versus $304000.0 for Q2 2025 and $255000.0 for Q1 2025.